Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages

Takumi Hirata, Yasumichi Arai (), Shinsuke Yuasa, Yukiko Abe, Michiyo Takayama, Takashi Sasaki, Akira Kunitomi, Hiroki Inagaki, Motoyoshi Endo, Jun Morinaga, Kimio Yoshimura, Tetsuo Adachi, Yuichi Oike, Toru Takebayashi, Hideyuki Okano and Nobuyoshi Hirose
Additional contact information
Takumi Hirata: Keio University School of Medicine
Yasumichi Arai: Keio University School of Medicine
Shinsuke Yuasa: Keio University School of Medicine
Yukiko Abe: Keio University School of Medicine
Michiyo Takayama: Keio University School of Medicine
Takashi Sasaki: Keio University School of Medicine
Akira Kunitomi: Keio University School of Medicine
Hiroki Inagaki: Tokyo Metropolitan Institute of Gerontology
Motoyoshi Endo: Kumamoto University
Jun Morinaga: Kumamoto University
Kimio Yoshimura: Keio University School of Medicine
Tetsuo Adachi: Gifu Pharmaceutical University
Yuichi Oike: Kumamoto University
Toru Takebayashi: Keio University School of Medicine
Hideyuki Okano: Keio University School of Medicine
Nobuyoshi Hirose: Keio University School of Medicine

Nature Communications, 2020, vol. 11, issue 1, 1-17

Abstract: Abstract Supercentenarians (those aged ≥110 years) are approaching the current human longevity limit by preventing or surviving major illness. Identifying specific biomarkers conducive to exceptional survival might provide insights into counter-regulatory mechanisms against aging-related disease. Here, we report associations between cardiovascular disease-related biomarkers and survival to the highest ages using a unique dataset of 1,427 oldest individuals from three longitudinal cohort studies, including 36 supercentenarians, 572 semi-supercentenarians (105–109 years), 288 centenarians (100–104 years), and 531 very old people (85–99 years). During follow-up, 1,000 participants (70.1%) died. Overall, N-terminal pro-B-type natriuretic peptide (NT-proBNP), interleukin-6, cystatin C and cholinesterase are associated with all-cause mortality independent of traditional cardiovascular risk factors and plasma albumin. Of these, low NT-proBNP levels are statistically associated with a survival advantage to supercentenarian age. Only low albumin is associated with high mortality across age groups. These findings expand our knowledge on the biology of human longevity.

Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-020-17636-0 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17636-0

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-020-17636-0

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().